Related Experiment Video
Updated: Jul 5, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
Risk modelling for vaccination: a risk assessment perspective.
1Centre for Epidemiology and Risk Analysis, Veterinary Laboratories Agency, New Haw, Addlestone, Surrey, England. m.wooldridge@vla.defra.gsi.gov.uk
This study outlines the essential steps for risk assessment, focusing on avian influenza vaccines. It details hazard identification and risk evaluation processes for vaccine manufacture and use, considering technical and biological factors.
Area of Science:
- Veterinary Vaccinology
- Risk Assessment Methodology
- Biosecurity and Public Health
Background:
- Risk assessment is a multi-step process crucial for evaluating potential dangers.
- Avian influenza vaccines present unique risks during manufacture and field application.
- Understanding these risks is vital for effective disease control strategies.
Purpose of the Study:
- To delineate the systematic steps involved in conducting a comprehensive risk assessment for avian influenza vaccines.
- To identify and categorize potential hazards associated with vaccine development, production, and deployment.
- To provide a framework for evaluating risks, including considerations for qualitative and quantitative approaches.
Main Methods:
- Systematic identification of risk questions relevant to avian influenza vaccines.
- Hazard identification encompassing technical errors and pathogen-specific properties.
- Outline of information requirements and assessment steps for field vaccine use.
- Discussion of qualitative versus quantitative risk assessment and impact of uncertainty.
Main Results:
- A structured approach to risk assessment for avian influenza vaccines is presented.
- Potential hazards include manufacturing defects (e.g., contamination) and vaccine-related pathogen issues (e.g., reversion to virulence).
- The assessment considers risks from production to in-field application and disease control failure.
Conclusions:
- Effective risk assessment requires careful hazard identification and evaluation.
- Both technical and biological factors must be considered for avian influenza vaccines.
- The methodology supports informed decision-making in vaccine deployment and biosecurity.
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Vaccinations
Relative Risk
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Steps in Outbreak Investigation
Smallpox